Your browser doesn't support javascript.
loading
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis.
Sharma, Shagun; Agnihotri, Navneet; Kumar, Sandeep.
Afiliación
  • Sharma S; Department of Biochemistry, BMS Block II, Sector 25, Panjab University, Chandigarh 160014, India.
  • Agnihotri N; Department of Biochemistry, BMS Block II, Sector 25, Panjab University, Chandigarh 160014, India. Electronic address: navneet_agnihotri@pu.ac.in.
  • Kumar S; Department of Life Sciences, J C Bose University of Science and Technology YMCA, Sector 6, Faridabad, Haryana 121006, India. Electronic address: skmahiwal@jcboseust.ac.in.
Biochem Pharmacol ; 198: 114943, 2022 04.
Article en En | MEDLINE | ID: mdl-35131295
ABSTRACT
Advances in cell metabolism over the past few decades have demonstrated glutamine as an essential nutrient for cancer cell survival and proliferation. Glutamine offers a remarkable capacity to fuel diverse metabolic pathways in cancer cells including the Krebs cycle, maintenance of redox homeostasis, and synthesis of cellular building blocks such as nucleic acids, fatty acids, glutathione, and other amino acids. The increase in glutaminolysis has further been linked to the accumulation of oncometabolites such as 2HG (2-Hydroxyglutarate), succinate, fumarate, etc., thereby contributing to tumorigenesis via regulating epigenetic modification of imprinted genes. Therefore, therapeutic targeting of glutaminolysis in cancer cells is worth exploring for possible treatment strategies for cancer management. In this review, we have discussed the detailed mechanism of glutamine uptake, transport, and its instrumental role in rewiring the metabolic adaptation of cancer cells in the tumor microenvironment under nutrient deprivation and hypoxia. Furthermore, we have attempted to provide an updated therapeutic intervention of glutamine metabolism as a treatment strategy for cancer management.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glutamina / Neoplasias Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glutamina / Neoplasias Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: India